Smith Cynthia
SEC CIK 1609480 · EDGAR
Most active insiders at SPRO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rajavelu Esther | See Remarks | — | $406.8K |
| 2 | Keutzer Timothy | COO | — | $145.2K |
| 3 | Tregoning Kathleen | Dir | — | — |
| 4 | Zack Debra | Chief Medical Off | — | — |
| 5 | Smith Cynthia | Dir | — | — |
| 6 | Jackson Scott Thomas | Dir | — | — |
| 7 | VINK PATRICK V.J.J. | Dir | — | — |
| 8 | Deshpande Milind | Dir | — | — |
| 9 | Pottage John C Jr | Dir | — | — |
| 10 | THOMAS FRANK E | Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-25 19:14 | 2026-06-23 | SPRO | Spero Therapeutics, Inc. | Smith Cynthia | Dir | A - Grant | $0.00 | +10.0K | 85.0K | +13% | $0 |
| D | 2026-06-23 17:19 | 2026-06-18 | AGIO | AGIOS PHARMACEUTICALS, INC. | Smith Cynthia | Dir | M - OptEx | $0.00 | +2,816 | 15.2K | +23% | $0 |
| D | 2026-06-22 16:23 | 2026-06-17 | AKBA | Akebia Therapeutics, Inc. | Smith Cynthia | Dir | A - Grant | $0.00 | +35.7K | 196.6K | +22% | $0 |
| D | 2025-08-13 | 2025-08-11 | AGIO | AGIOS PHARMACEUTICALS, INC. | Smith Cynthia | Dir | M - OptEx | $0.00 | +2,302 | 12.4K | +23% | $0 |
| D | 2025-06-23 | 2025-06-20 | AGIO | AGIOS PHARMACEUTICALS, INC. | Smith Cynthia | Dir | M - OptEx | $0.00 | +2,120 | 10.1K | +27% | $0 |
| 2025-06-16 | 2025-06-12 | SPRO | Spero Therapeutics, Inc. | Smith Cynthia | Dir | A - Grant | $0.00 | +20.0K | 75.0K | +36% | $0 | |
| D | 2025-06-11 | 2025-06-10 | AKBA | Akebia Therapeutics, Inc. | Smith Cynthia | Dir | A - Grant | $0.00 | +35.7K | 160.9K | +29% | $0 |
| D | 2024-08-13 | 2024-08-11 | AGIO | AGIOS PHARMACEUTICALS, INC. | Smith Cynthia | Dir | M - OptEx | $0.00 | +2,302 | 7,992 | +40% | $0 |
| D | 2024-06-17 | 2024-06-13 | AGIO | AGIOS PHARMACEUTICALS, INC. | Smith Cynthia | Dir | M - OptEx | $0.00 | +3,388 | 5,690 | +147% | $0 |
| D | 2024-06-10 | 2024-06-06 | AKBA | Akebia Therapeutics, Inc. | Smith Cynthia | Dir | A - Grant | $0.00 | +30.0K | 125.2K | +32% | $0 |
| 2024-05-30 | 2024-05-29 | SPRO | Spero Therapeutics, Inc. | Smith Cynthia | Dir | A - Grant | $0.00 | +20.0K | 55.0K | +57% | $0 | |
| 2023-10-10 | 2023-10-05 | SPRO | Spero Therapeutics, Inc. | Smith Cynthia | Dir | A - Grant | $0.00 | +20.0K | 35.0K | +133% | $0 | |
| D | 2023-08-15 | 2023-08-11 | AGIO | AGIOS PHARMACEUTICALS, INC. | Smith Cynthia | Dir | M - OptEx | $0.00 | +2,302 | 2,302 | New | $0 |
| D | 2023-06-08 | 2023-06-06 | AKBA | Akebia Therapeutics, Inc. | Smith Cynthia | Dir | A - Grant | $0.00 | +30.0K | 95.2K | +46% | $0 |
| 2022-09-19 | 2022-09-15 | SPRO | Spero Therapeutics, Inc. | Smith Cynthia | Dir | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 | |
| D | 2022-06-09 | 2022-06-08 | AKBA | Akebia Therapeutics, Inc. | Smith Cynthia | Dir | A - Grant | $0.00 | +13.7K | 65.2K | +27% | $0 |
Purchase Sale Sale after option exercise All abbreviations